The drug developer is buying biotechnology firm
The biotechnology company is being bought by
The maker of flavors and fragrances is a potential buyer for DuPont's nutrition business, according to
The pharmaceutical company issued an upbeat update on the early development of a potential cancer treatment.
The specialty pharmacy is being bought by
The biotechnology company said early development of a potential stem-cell based cancer treatment is going well.
The regional bank operator is buying
The company is buying back
Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed., source